Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 307-312

  Hsueh, Po Ren ^a   Lee, Shih Yi ^b   Perng, Cherng Lih ^c   Chang, Tein Yao ^c   Lu, Jang Jih ^c,d,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Clonal dissemination; Taiwan; Vancomycin intermediate Staphylococcus aureus; VISA

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CEFTOBIPROLE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; PANTON VALENTINE LEUKOCIDIN; PROTEIN VANA; PROTEIN VANB; PROTEIN VANC; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; GENE AMPLIFICATION; HOSPITAL PATIENT; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TAIWAN; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 77955918052     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.035     Document Type: Article

References (43)

1. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
2. Boucher H.W., Corey G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl. 5):S344-S349.
3. Rosenthal V.D., Maki D.G., Mehta A., Alvarez-Moreno C., Leblebicioglu H., Higuera F., et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008, 36:627-637.
4. Hsueh P.R., Teng L.J., Chen W.H., Pan H.J., Chen M.L., Chang S.C., et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 2004, 48:1361-1364.
5. Hsueh P.R., Chen W.H., Teng L.J., Luh K.T. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005, 30:143-149.
6. Bierbaum G., Fuchs K., Lenz W., Szekat C., Sahl H.G. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999, 18:691-696.
7. Kim M.N., Pai C.H., Woo J.H., Ryu J.S., Hiramatsu K. Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol 2000, 38:3879-3881.
8. Marchese A., Balistreri G., Tonoli E., Debbia E.A., Schito G.C. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 2000, 38:866-869.
9. Ploy M.C., Grelaud C., Martin C., de Lumley L., Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998, 351:1212.
10. Trakulsomboon S., Danchaivijitr S., Rongrungruang Y., Dhiraputra C., Susaemgrat W., Ito T., et al. The first report on methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol 2001, 39:591-595.
11. Lu J.J., Lee S.Y., Hwa S.Y., Yang A.H. Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2005, 43:4156-4158.
12. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
13. Ho C.M., Hsueh P.R., Liu C.Y., Lee S.Y., Chiueh T.S., Shyr J.M., et al. Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan-SMART program, 2003. Eur J Clin Microbiol Infect Dis 2010, 29:383-389.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard. 9th ed. Document M2-A9. Wayne, PA: CLSI; 2006.
15. Adhikari R.P., Cook G.M., Lamont I., Lang S., Heffernan H., Smith J.M. Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2002, 50:825-831.
16. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2009.
18. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997, 350:1670-1673.
19. Lu J.J., Perng C.L., Chiueh T.S., Lee S.Y., Chen C.H., Chang F.Y., et al. Detection and typing of vancomycin-resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR. Epidemiol Infect 2001, 126:357-363.
20. Huang Y.H., Tseng S.P., Hu J.M., Tsai J.C., Hsueh P.R., Teng L.J. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect 2007, 13:717-724.
21. Mani N., Tobin P., Jayaswal R.K. Isolation and characterization of autolysis-defective mutants of Staphylococcus aureus created by Tn917-lacZ mutagenesis. J Bacteriol 1993, 175:1493-1499.
22. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
23. Mulvey M.R., Chui L., Ismail J., Louie L., Murphy C., Chang N., et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001, 39:3481-3485.
24. Denis O., Nonhoff C., Byl B., Knoop C., Bobin-Dubreux S., Struelens M.J. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J Antimicrob Chemother 2002, 50:383-391.
25. Garnier F., Chainier D., Walsh T., Karlsson A., Bolmström A., Grelaud C., et al. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother 2006, 57:146-149.
26. Sancak B., Ercis S., Menemenlioglu D., Colakoglu S., Hasçelik G. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005, 56:519-523.
27. Mallaval F.O., Carricajo A., Delavenna F., Recule C., Fonsale N., Manquat G., et al. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin Microbiol Infect 2004, 10:459-461.
28. Sievert D.M., Rudrik J.T., Patel J.B., McDonald L.C., Wilkins M.J., Hageman J.C. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008, 46:675-677.
29. Tenover F.C., Weigel L.M., Appelbaum P.C., McDougal L.K., Chaitram J., McAllister S., et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004, 48:275-280.
30. Cui L., Ma X., Sato K., Tenover F.C., Mamizuka E.M., Gemmell C.G., et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003, 41:5-14.
31. Sakoulas G., Eliopoulos G.M., Moellering R.C., Schentag J.J., Forrest A., Moellering R.F., et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002, 46:1492-1502.
32. Abdelnour A., Arvidson S., Bremell T., Ryden C., Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993, 61:3879-3885.
33. Vuong C., Saenz H.L., Gotz F., Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 2000, 182:1688-1693.
34. Sakoulas G. The accessory gene regulator (agr) in methicillin-resistant Staphylococcus aureus: role in virulence and reduced susceptibility to glycopeptides antibiotics. Drug Discov Today 2006, 3:287-294.
35. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001, 1:147-155.
36. Biedenbach D.J., Bell J.M., Sader H.S., Fritsche T.R., Jones R.N., Turnidge J.D. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int J Antimicrob Agents 2007, 30:143-149.
37. Critchley I.A., Blosser-Middleton R.S., Jones M.E., Thornsberry C., Sahm D.F., Karlowsky J.A. Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000-2001. Antimicrob Agents Chemother 2003, 47:1688-1693.
38. Cui L., Tominaga E., Neoh H.M., Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006, 50:1079-1082.
39. Sader H.S., Fritsche T.R., Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob Agents Chemother 2006, 50:2330-2336.
40. Huang Y.T., Hsiao C.H., Liao C.H., Lee C.W., Hsueh P.R. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan. J Clin Microbiol 2008, 46:1132-1136.
41. Kuo C.C., Wu V.C., Huang Y.T., Liao C.H., Hsueh P.R. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease. Int J Antimicrob Agents 2008, 33:96-98.
42. Kuo C.C., Wu V.C., Tsai W., Chou N.K., Wang S.S., Hsueh P.R. Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 47:859-860.
43. Mwangi M.M., Wu S.W., Zhou Y., Sieradzki K., de Lencastre H., Richardson P., et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 2007, 104:9451-9456.